The news report: Friday, April 17, 2009

In today’s news reports we address:

  • Prediction of freedom from biochemical failure after brachytherapy
  • Prediction of probability of unilateral prostate cancer in men eligible for focal therapy
  • Health-related quality of life 5 years after radiotherapy + androgen deprivation
  • Androgen receptor activity “signatures” in men with CRPC … READ MORE …

Further defining the potential for focal therapy

A study from investigators at M. D. Anderson Cancer Center has attempted to assess the likelihood of total eradication of prostate cancer in men with prostate cancer that is found in only one lobe of the prostate and who would  qualify for subtotal prostate ablation with controlled thermal energy using such techniques as cryoablation or high-intensity focused ultrasound. … READ MORE …

The weekend news reports: March 7, 2009

This weekend’s news includes items on:

  • The ongoing major prostate cancer screening trials
  • The changing landscape of first-line management for early stage, low risk prostate cancer
  • Outcomes of RALP procedures in which surgical fellows participate
  • Hypofractionation procedures in radiotherapeutic treatment
  • The current state of sexual rehabilitation post-prostatectomy … READ MORE …

The Thursday news report: March 5, 2009

There are a significant number of relatively long-term news items in today’s report. Of most immediate interest to the majority of prostate cancer patients and educators we include reports on:

  • The fact that over 70 percent of cancers thought to be unilateral at biopsy turn out to be bilateral post-surgery (which has implications for focal therapy)
  • The availability of degarelix for actual prescription and clinical use in the USA
  • The formation of a specialized new urologic oncology research institute at UCLA … READ MORE …

More from the GU oncology symposium — Part 2

During the oral sessions on prostate cancer management yesterday, there were two topics that generated significant differences of opinion between presenters: the relative benefits of salvage vs. adjuvant radiotherapy in men post-surgery and whether focal therapy (whether executed with HIFU or cryotherapy or any other means) is actually a valid from of treatment. … READ MORE …

The Thursday news reports: February 27, 2009

In news from sources other than the Genitourinary Cancer Symposium today, we have six reports on:

  • Oxidative stress and the development of prostate cancer
  • A review of PSA kinetics in the diagnosis, prognosis, and monitoring of prstate cancer
  • Focal therapy in general and focal cryoablation specifically
  • The relevance of elevated chondroitin sulphate levels and androgen receptor levels to prostate cancer progression … READ MORE …

Thursday’s other news reports: February 5, 2009

There are a number of additional reports in today’s news (above and beyond the reports on risks associated with disseminated tumor cells and a new review of PSA and PCA3 testing as aids to diagnosis): … READ MORE …

Who is an appropriate candidate for focal therapy, and how do we know?

Yesterday we posted a commentary on a review by Marberger et al. that addressed the potential of certain techniques as focal therapies for localized forms of prostate cancer. … READ MORE …

“New” treatments for localized prostate cancer: an expert overview

A small international group of very highly respected experts has just published an important review of the current evidence surrounding the application of a  number of the new and/or evolving treatments available for management of localized prostate cancer, with an emphasis on the potential of focal therapy. … READ MORE …

Reports from the Society for Urologic Oncology

UroToday has just published a whole series of reports from the annual end-of-year meeting of the Society for Urologic Oncology. Some of these reports will be of interest to the more knowledgeable prostate cancer patients and advocates. … READ MORE …

Tuesday’s prostate cancer news: October 14, 2008

In today’s update there is information about:

  • Excess body mass and risk from prostate cancer death
  • The potential role of the PCA3 test
  • Focal treatment for localized disease using targeted photodynamic therapy … READ MORE …